report cover

Global Covid-19 Therapeutic Market Size, Status and Forecast 2022-2028

  • 26 August 2022
  • ICT & Media
  • 96 Pages
  • Report code : 24WT-7297529

Covid-19 Therapeutic Market

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Covid-19 Therapeutic Market Size Growth Rate by Type (2022-2028)
1.2.2 Immunotherapy
1.2.3 Life Support
1.2.4 Antiviral Medicine
1.2.5 Plasma Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Covid-19 Therapeutic Market Share by Application (2022-2028)
1.3.2 Children
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Covid-19 Therapeutic Market Size
2.2 Covid-19 Therapeutic Market Size by Regions
2.2.1 Covid-19 Therapeutic Growth Rate by Regions (2022-2028)
2.2.2 Covid-19 Therapeutic Market Share by Regions (2022-2028)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 Covid-19 Therapeutic Revenue by Players (2022 & 2028)
3.2 Covid-19 Therapeutic Key Players Headquarters and Area Served
3.3 Key Players Covid-19 Therapeutic Product/Solution/Service
3.4 Date of Enter into Covid-19 Therapeutic Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global Covid-19 Therapeutic Market Size by Type (2022-2028)
4.2 Global Covid-19 Therapeutic Market Size by Application (2022-2028)
5 North America
5.1 North America Covid-19 Therapeutic Market Forecast (2022-2028)
5.2 Covid-19 Therapeutic Key Players in North America
5.3 North America Covid-19 Therapeutic Market Size by Type
5.4 North America Covid-19 Therapeutic Market Size by Application
6 Europe
6.1 Europe Covid-19 Therapeutic Market Forecast (2022-2028)
6.2 Covid-19 Therapeutic Key Players in Europe
6.3 Europe Covid-19 Therapeutic Market Size by Type
6.4 Europe Covid-19 Therapeutic Market Size by Application
7 Asia-Pacific
7.1 Asia-Pacific Covid-19 Therapeutic Market Forecast (2022-2028)
7.2 Covid-19 Therapeutic Key Players in Asia-Pacific
7.3 Asia-Pacific Covid-19 Therapeutic Market Size by Type
7.4 Asia-Pacific Covid-19 Therapeutic Market Size by Application
8 Rest of World
8.1 Latin America
8.1.1 Latin America Covid-19 Therapeutic Market Analysis
8.1.2 Key Players in Latin America
8.2 Middle East & Africa
8.2.1 Middle East & Africa Covid-19 Therapeutic Market Analysis
8.2.2 Key Players in Middle East & Africa
9 International Player Profiles
9.1 Cadila Healthcare
9.1.1 Cadila Healthcare Company Details
9.1.2 Cadila Healthcare Description and Business Overview
9.1.3 Cadila Healthcare Covid-19 Therapeutic Introduction
9.1.4 Cadila Healthcare Revenue in Covid-19 Therapeutic Business (2022 & 2028)
9.1.5 Cadila Healthcare Recent Development
9.2 Johnson & Johnson
9.2.1 Johnson & Johnson Company Details
9.2.2 Johnson & Johnson Description and Business Overview
9.2.3 Johnson & Johnson Covid-19 Therapeutic Introduction
9.2.4 Johnson & Johnson Revenue in Covid-19 Therapeutic Business (2022 & 2028)
9.2.5 Johnson & Johnson Recent Development
9.3 ImmunoPrecise
9.3.1 ImmunoPrecise Company Details
9.3.2 ImmunoPrecise Description and Business Overview
9.3.3 ImmunoPrecise Covid-19 Therapeutic Introduction
9.3.4 ImmunoPrecise Revenue in Covid-19 Therapeutic Business (2022 & 2028)
9.3.5 ImmunoPrecise Recent Development
9.4 Novartis
9.4.1 Novartis Company Details
9.4.2 Novartis Description and Business Overview
9.4.3 Novartis Covid-19 Therapeutic Introduction
9.4.4 Novartis Revenue in Covid-19 Therapeutic Business (2022 & 2028)
9.4.5 Novartis Recent Development
9.5 AstraZeneca
9.5.1 AstraZeneca Company Details
9.5.2 AstraZeneca Description and Business Overview
9.5.3 AstraZeneca Covid-19 Therapeutic Introduction
9.5.4 AstraZeneca Revenue in Covid-19 Therapeutic Business (2022 & 2028)
9.5.5 AstraZeneca Recent Development
9.6 Cipla
9.6.1 Cipla Company Details
9.6.2 Cipla Description and Business Overview
9.6.3 Cipla Covid-19 Therapeutic Introduction
9.6.4 Cipla Revenue in Covid-19 Therapeutic Business (2022 & 2028)
9.6.5 Cipla Recent Development
9.7 AbbVie
9.7.1 AbbVie Company Details
9.7.2 AbbVie Description and Business Overview
9.7.3 AbbVie Covid-19 Therapeutic Introduction
9.7.4 AbbVie Revenue in Covid-19 Therapeutic Business (2022 & 2028)
9.7.5 AbbVie Recent Development
9.8 Bayer
9.8.1 Bayer Company Details
9.8.2 Bayer Description and Business Overview
9.8.3 Bayer Covid-19 Therapeutic Introduction
9.8.4 Bayer Revenue in Covid-19 Therapeutic Business (2022 & 2028)
9.8.5 Bayer Recent Development
9.9 Regeneron Pharmaceuticals
9.9.1 Regeneron Pharmaceuticals Company Details
9.9.2 Regeneron Pharmaceuticals Description and Business Overview
9.9.3 Regeneron Pharmaceuticals Covid-19 Therapeutic Introduction
9.9.4 Regeneron Pharmaceuticals Revenue in Covid-19 Therapeutic Business (2022 & 2028)
9.9.5 Regeneron Pharmaceuticals Recent Development
9.10 Ascletis Pharma
9.10.1 Ascletis Pharma Company Details
9.10.2 Ascletis Pharma Description and Business Overview
9.10.3 Ascletis Pharma Covid-19 Therapeutic Introduction
9.10.4 Ascletis Pharma Revenue in Covid-19 Therapeutic Business (2022 & 2028)
9.10.5 Ascletis Pharma Recent Development
9.11 GlaxoSmithKline
9.11.1 GlaxoSmithKline Company Details
9.11.2 GlaxoSmithKline Description and Business Overview
9.11.3 GlaxoSmithKline Covid-19 Therapeutic Introduction
9.11.4 GlaxoSmithKline Revenue in Covid-19 Therapeutic Business (2022 & 2028)
9.11.5 GlaxoSmithKline Recent Development
9.12 Gilead Sciences
9.12.1 Gilead Sciences Company Details
9.12.2 Gilead Sciences Description and Business Overview
9.12.3 Gilead Sciences Covid-19 Therapeutic Introduction
9.12.4 Gilead Sciences Revenue in Covid-19 Therapeutic Business (2022 & 2028)
9.12.5 Gilead Sciences Recent Development
9.13 Pharmstandard
9.13.1 Pharmstandard Company Details
9.13.2 Pharmstandard Description and Business Overview
9.13.3 Pharmstandard Covid-19 Therapeutic Introduction
9.13.4 Pharmstandard Revenue in Covid-19 Therapeutic Business (2022 & 2028)
9.13.5 Pharmstandard Recent Development
9.14 Fujifilm Holdings
9.14.1 Fujifilm Holdings Company Details
9.14.2 Fujifilm Holdings Description and Business Overview
9.14.3 Fujifilm Holdings Covid-19 Therapeutic Introduction
9.14.4 Fujifilm Holdings Revenue in Covid-19 Therapeutic Business (2022 & 2028)
9.14.5 Fujifilm Holdings Recent Development
9.15 Zhejiang Hisun Pharmaceutical Co. Ltd
9.15.1 Zhejiang Hisun Pharmaceutical Co. Ltd Company Details
9.15.2 Zhejiang Hisun Pharmaceutical Co. Ltd Description and Business Overview
9.15.3 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Therapeutic Introduction
9.15.4 Zhejiang Hisun Pharmaceutical Co. Ltd Revenue in Covid-19 Therapeutic Business (2022 & 2028)
9.15.5 Zhejiang Hisun Pharmaceutical Co. Ltd Recent Development
9.16 Roche
9.16.1 Company Details
9.16.2 Roche Description and Business Overview
9.16.3 Roche Covid-19 Therapeutic Introduction
9.16.4 Roche Revenue in Covid-19 Therapeutic Business (2022 & 2028)
9.16.5 Roche Recent Development
9.17 Sanofi
9.17.1 Sanofi Company Details
9.17.2 Sanofi Description and Business Overview
9.17.3 Sanofi Covid-19 Therapeutic Introduction
9.17.4 Sanofi Revenue in Covid-19 Therapeutic Business (2022 & 2028)
9.17.5 Sanofi Recent Development
9.18 Pfizer
9.18.1 Pfizer Company Details
9.18.2 Pfizer Description and Business Overview
9.18.3 Pfizer Covid-19 Therapeutic Introduction
9.18.4 Pfizer Revenue in Covid-19 Therapeutic Business (2022 & 2028)
9.18.5 Pfizer Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. Global Covid-19 Therapeutic Market Size Growth Rate by Type (2022-2028) (US$ Million)
Table 2. Key Players of Immunotherapy
Table 3. Key Players of Life Support
Table 4. Key Players of Antiviral Medicine
Table 5. Key Players of Plasma Therapy
Table 6. Key Players of Others
Table 7. Global Covid-19 Therapeutic Market Size Growth by Application (2022-2028) (US$ Million)
Table 8. Global Covid-19 Therapeutic Market Size by Regions (2022-2028) (US$ Million)
Table 9. Global Covid-19 Therapeutic Market Share by Regions (2022-2028)
Table 10. Market Top Trends
Table 11. Market Use Cases
Table 12. Global Covid-19 Therapeutic Revenue by Players (2022 & 2028) (US$ Million)
Table 13. Global Covid-19 Therapeutic Market Share by Players (2022 &2028)
Table 14. Key Players Headquarters and Area Served
Table 15. Key Players Covid-19 Therapeutic Product/Solution/Service
Table 16. Date of Enter into Covid-19 Therapeutic Market
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Covid-19 Therapeutic Market Size by Type (2022-2028) (US$ Million)
Table 19. Global Covid-19 Therapeutic Market Size Share by Type (2022-2028)
Table 20. Global Covid-19 Therapeutic Market Size by Application (2022-2028) (US$ Million)
Table 21. Global Covid-19 Therapeutic Market Size Share by Application (2022-2028)
Table 22. North America Key Players Covid-19 Therapeutic Revenue (2022 & 2028) & (US$ Million)
Table 23. North America Key Players Covid-19 Therapeutic Market Share (2022 & 2028)
Table 24. North America Covid-19 Therapeutic Market Size by Type (2022-2028) (US$ Million)
Table 25. North America Covid-19 Therapeutic Market Share by Type (2022-2028)
Table 26. North America Covid-19 Therapeutic Market Size by Application (2022-2028) (US$ Million)
Table 27. North America Covid-19 Therapeutic Market Share by Application (2022-2028)
Table 28. Europe Key Players Covid-19 Therapeutic Revenue (2022 & 2028) & (US$ Million)
Table 29. Europe Key Players Covid-19 Therapeutic Market Share (2022 & 2028)
Table 30. Europe Covid-19 Therapeutic Market Size by Type (2022-2028) (US$ Million)
Table 31. Europe Covid-19 Therapeutic Market Share by Type (2022-2028)
Table 32. Europe Covid-19 Therapeutic Market Size by Application (2022-2028) (US$ Million)
Table 33. Europe Covid-19 Therapeutic Market Share by Application (2022-2028)
Table 34. Asia-Pacific Key Players Covid-19 Therapeutic Revenue (2022 & 2028) & (US$ Million)
Table 35. Asia-Pacific Key Players Covid-19 Therapeutic Market Share (2022 & 2028)
Table 36. Asia-Pacific Covid-19 Therapeutic Market Size by Type (2022-2028) (US$ Million)
Table 37. Asia-Pacific Covid-19 Therapeutic Market Share by Type (2022-2028)
Table 38. Asia-Pacific Covid-19 Therapeutic Market Size by Application (2022-2028) (US$ Million)
Table 39. Asia-Pacific Covid-19 Therapeutic Market Share by Application (2022-2028)
Table 40. Key Players in Latin America
Table 41. Key Players in Middle East & Africa
Table 42. Cadila Healthcare Company Details
Table 43. Cadila Healthcare Description and Business Overview
Table 44. Cadila Healthcare Covid-19 Therapeutic Product
Table 45. Cadila Healthcare Revenue in Covid-19 Therapeutic Business 2022 & 2028
Table 46. Cadila Healthcare Recent Development
Table 47. Johnson & Johnson Company Details
Table 48. Johnson & Johnson Description and Business Overview
Table 49. Johnson & Johnson Covid-19 Therapeutic Product
Table 50. Johnson & Johnson Revenue in Covid-19 Therapeutic Business 2022 & 2028
Table 51. Johnson & Johnson Recent Development
Table 52. ImmunoPrecise Company Details
Table 53. ImmunoPrecise Description and Business Overview
Table 54. ImmunoPrecise Covid-19 Therapeutic Product
Table 55. ImmunoPrecise Revenue in Covid-19 Therapeutic Business 2022 & 2028
Table 56. ImmunoPrecise Recent Development
Table 57. Novartis Company Details
Table 58. Novartis Description and Business Overview
Table 59. Novartis Covid-19 Therapeutic Product
Table 60. Novartis Revenue in Covid-19 Therapeutic Business 2022 & 2028
Table 61. Novartis Recent Development
Table 62. AstraZeneca Company Details
Table 63. AstraZeneca Description and Business Overview
Table 64. AstraZeneca Covid-19 Therapeutic Product
Table 65. AstraZeneca Revenue in Covid-19 Therapeutic Business 2022 & 2028
Table 66. AstraZeneca Recent Development
Table 67. Cipla Company Details
Table 68. Cipla Description and Business Overview
Table 69. Cipla Covid-19 Therapeutic Product
Table 70. Cipla Revenue in Covid-19 Therapeutic Business 2022 & 2028
Table 71. Cipla Recent Development
Table 72. AbbVie Company Details
Table 73. AbbVie Description and Business Overview
Table 74. AbbVie Covid-19 Therapeutic Product
Table 75. AbbVie Revenue in Covid-19 Therapeutic Business 2022 & 2028
Table 76. AbbVie Recent Development
Table 77. Bayer Company Details
Table 78. Bayer Description and Business Overview
Table 79. Bayer Covid-19 Therapeutic Product
Table 80. Bayer Revenue in Covid-19 Therapeutic Business 2022 & 2028
Table 81. Bayer Recent Development
Table 82. Regeneron Pharmaceuticals Company Details
Table 83. Regeneron Pharmaceuticals Description and Business Overview
Table 84. Regeneron Pharmaceuticals Covid-19 Therapeutic Product
Table 85. Regeneron Pharmaceuticals Revenue in Covid-19 Therapeutic Business 2022 & 2028
Table 86. Regeneron Pharmaceuticals Recent Development
Table 87. Ascletis Pharma Company Details
Table 88. Ascletis Pharma Description and Business Overview
Table 89. Ascletis Pharma Covid-19 Therapeutic Product
Table 90. Ascletis Pharma Revenue in Covid-19 Therapeutic Business 2022 & 2028
Table 91. Ascletis Pharma Recent Development
Table 92. GlaxoSmithKline Company Details
Table 93. GlaxoSmithKline Description and Business Overview
Table 94. GlaxoSmithKline Covid-19 Therapeutic Product
Table 95. GlaxoSmithKline Revenue in Covid-19 Therapeutic Business 2022 & 2028
Table 96. GlaxoSmithKline Recent Development
Table 97. Gilead Sciences Company Details
Table 98. Gilead Sciences Description and Business Overview
Table 99. Gilead Sciences Covid-19 Therapeutic Product
Table 100. Gilead Sciences Revenue in Covid-19 Therapeutic Business 2022 & 2028
Table 101. Gilead Sciences Recent Development
Table 102. Pharmstandard Company Details
Table 103. Pharmstandard Description and Business Overview
Table 104. Pharmstandard Covid-19 Therapeutic Product
Table 105. Pharmstandard Revenue in Covid-19 Therapeutic Business 2022 & 2028
Table 106. Pharmstandard Recent Development
Table 107. Fujifilm Holdings Company Details
Table 108. Fujifilm Holdings Description and Business Overview
Table 109. Fujifilm Holdings Covid-19 Therapeutic Product
Table 110. Fujifilm Holdings Revenue in Covid-19 Therapeutic Business 2022 & 2028
Table 111. Fujifilm Holdings Recent Development
Table 112. Zhejiang Hisun Pharmaceutical Co. Ltd Company Details
Table 113. Zhejiang Hisun Pharmaceutical Co. Ltd Description and Business Overview
Table 114. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Therapeutic Product
Table 115. Zhejiang Hisun Pharmaceutical Co. Ltd Revenue in Covid-19 Therapeutic Business 2022 & 2028
Table 116. Zhejiang Hisun Pharmaceutical Co. Ltd Recent Development
Table 117. Roche Company Details
Table 118. Roche Description and Business Overview
Table 119. Roche Covid-19 Therapeutic Product
Table 120. Roche Revenue in Covid-19 Therapeutic Business 2022 & 2028
Table 121. Roche Recent Development
Table 122. Sanofi Company Details
Table 123. Sanofi Description and Business Overview
Table 124. Sanofi Covid-19 Therapeutic Product
Table 125. Sanofi Revenue in Covid-19 Therapeutic Business 2022 & 2028
Table 126. Sanofi Recent Development
Table 127. Pfizer Company Details
Table 128. Pfizer Description and Business Overview
Table 129. Pfizer Covid-19 Therapeutic Product
Table 130. Pfizer Revenue in Covid-19 Therapeutic Business 2022 & 2028
Table 131. Pfizer Recent Development
Table 132. Covid-19 Therapeutic Market Trends
Table 133. Covid-19 Therapeutic Market Drivers
Table 134. Covid-19 Therapeutic Market Challenges
Table 135. Covid-19 Therapeutic Market Restraints
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Covid-19 Therapeutic Market Share by Type in 2022 & 2028
Figure 2. Immunotherapy Features
Figure 3. Life Support Features
Figure 4. Antiviral Medicine Features
Figure 5. Plasma Therapy Features
Figure 6. Others Features
Figure 7. Global Covid-19 Therapeutic Market Share by Application in 2022 & 2028
Figure 8. Children Case Studies
Figure 9. Adult Case Studies
Figure 10. Covid-19 Therapeutic Report Years Considered
Figure 11. Global Covid-19 Therapeutic Market Size and Growth Rate (2022-2028) (US$ Million)
Figure 12. Global Covid-19 Therapeutic Market Share by Regions (2022-2028)
Figure 13. Global Covid-19 Therapeutic Market Share by Players in 2021
Figure 14. Global Covid-19 Therapeutic Market Size Market Share by Type (2022-2028)
Figure 15. Global Covid-19 Therapeutic Market Size Market Share by Application (2022-2028)
Figure 16. Global Covid-19 Therapeutic Revenue Market Share by Application in 2021
Figure 17. North America Covid-19 Therapeutic Market Size 2022-2028 (US$ Million)
Figure 18. Europe Covid-19 Therapeutic Market Size 2022-2028 (US$ Million)
Figure 19. Asia-Pacific Covid-19 Therapeutic Market Size 2022-2028 (US$ Million)
Figure 20. Covid-19 Therapeutic Market Size in Latin America (2022-2028) (US$ Million)
Figure 21. Covid-19 Therapeutic Market Size in Middle East & Africa (2022-2028) (US$ Million)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Covid-19 Therapeutic Market

Leave This Empty: